Results 261 to 270 of about 2,695,708 (355)

Medicare Part D and Hospital Admissions due to Antimicrobial Resistance

open access: yesHealth Economics, EarlyView.
ABSTRACT Antimicrobial resistance (AMR) has been increasing rapidly in the United States despite government efforts to contain its spread. Both under‐utilization and overuse of prescribed antimicrobials contribute to rising resistance. The introduction of Medicare Part D in 2006 expanded prescription drug coverage for the elderly, including coverage ...
Ricardo B. Ang III
wiley   +1 more source

HIV-1 Genetic Diversity and Drug Resistance Mutation Profiles in Donetsk, Luhansk and Zaporizhzhia Regions. [PDF]

open access: yesViruses
Antonova A   +12 more
europepmc   +1 more source

Cognitive Flexibility and Inhibition Deficits in HIV and Cocaine Dependence: Evidence from Stroop and Trail Making Tests. [PDF]

open access: yesViruses
Nigro SE   +13 more
europepmc   +1 more source

Mobile Wellness in the Workplace: Addressing the Global Men’s Healthcare Gap, from a World Health Organization Framework Perspective

open access: yesJournal of Epidemiology and Global Health
Stephanie Davis   +3 more
doaj   +1 more source

Applying human-centered design to adapt a multifaceted implementation strategy for integrating HIV and NCD services in Lusaka, Zambia: Healthcare worker perspectives. [PDF]

open access: yesPLOS Glob Public Health
Matenga TFL   +15 more
europepmc   +1 more source

Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV

open access: yesInternational Journal of Cancer, EarlyView.
What's New? This large nation‐wide cohort study provides a comprehensive 20‐year analysis of cancer trends among people living with HIV in France, highlighting persistent excess risks for virus‐related cancers despite effective antiretroviral therapy and immune restoration.
Sophie Grabar   +14 more
wiley   +1 more source

HIV-1 derived oligonucleotides induce a type I IFN/STING dependent immune suppression reversible by targeting IFNARI. [PDF]

open access: yesPLoS Pathog
Svanberg C   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy